Drug Development Pipeline | Pharma Analysis

Pharmapremia gives you the ability to accurately benchmark internal and external R&D candidates’ chances of approval and potential development timelines. You can use these benchmarks to make informed decisions about drug pipeline prioritization, partnerships and acquisitions.

How it can help

Pharmapremia allows you to look at product success factors across the variables that matter to you and your business. Its robust dataset includes detailed information from the entire drug-development industry, from big pharma to private biotech, oncology to orphan diseases.

This data gives you an exclusive window into drug development pipelines and paints a fuller, clearer picture of how the industry is performing.

How it works

Effectively manage your portfolio risk by accessing comprehensive data sets including Probability of Overall Success (POS), Likelihood of Approval (LOA) and Phase and Overall Duration.

Pharmapremia covers over 8,000 programs including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.

Find out how Pharmapremia helps you ensure regulatory success and effectively manage portfolio risk in this video.

Request a demo